Physician
Almalouf, Thaer
Almalouf, Thaer was paid $3.85M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.
33Billing provider infoALMALOUF, THAER
GREENSBURG, PA 15601
GREENSBURG, PA 15601
33aNPI1083706279assigned 09/28/2006
33bProvider typePediatrics Physician
28Total paid$3.85M
24GClaims108,556
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Pennsylvania
Rank by total paid#17 of 1,257
Median peer was paid$45K
This provider vs. median85×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,299 | $191K | |
| 2019 | 1,904 | $78K | |
| 2020 | 6,240 | $145K | |
| 2021 | 17,420 | $571K | |
| 2022 | 20,009 | $659K | |
| 2023 | 29,212 | $1.06M | |
| 2024incomplete | 29,472 | $1.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 26,977 | 23,759 | $1.62M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 3,467 | 3,441 | $388K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.6% | 3,627 | 3,592 | $371K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.6% | 4,562 | 4,310 | $332K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.0% | 2,205 | 2,166 | $231K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 2,126 | 2,107 | $219K |
| 99051 | 5.0% | 7,046 | 6,712 | $191K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 6,727 | 6,411 | $95K |
| 87428 | 1.8% | 2,053 | 1,995 | $70K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.4% | 1,297 | 1,264 | $52K |
| 99173 | 1.2% | 7,571 | 7,478 | $47K | |
| 92551 | 1.1% | 7,288 | 7,215 | $42K |
55 more codes
| G0008 | Administration of influenza virus vaccine | <1% | 1,769 | $22K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 614 | $20K |
| G0009 | Administration of pneumococcal vaccine | <1% | 1,265 | $15K |
| 92587 | <1% | 233 | $12K | |
| 99188 | <1% | 487 | $11K | |
| 90688 | <1% | 1,293 | $9K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 268 | $8K |
| 96161 | <1% | 1,505 | $7K | |
| 99381 | <1% | 56 | $6K | |
| 90749 | <1% | 450 | $6K | |
| 99072 | <1% | 690 | $6K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 399 | $6K |
| 90670 | <1% | 1,418 | $5K | |
| 90698 | <1% | 1,073 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 44 | $5K |
| 90686 | <1% | 1,141 | $4K | |
| 90680 | <1% | 1,260 | $4K | |
| 0071A | <1% | 134 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 112 | $3K |
| 90734 | <1% | 124 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 193 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 85 | $3K |
| 90633 | <1% | 1,088 | $3K | |
| 90744 | <1% | 539 | $3K | |
| 81002 | <1% | 617 | $3K | |
| 96127 | <1% | 2,458 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 109 | $2K |
| 0072A | <1% | 137 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,878 | $1K |
| 96160 | <1% | 2,745 | $1K | |
| 90651 | <1% | 722 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $1K |
| 90710 | <1% | 355 | $600.60 | |
| 90696 | <1% | 267 | $554.40 | |
| 90677 | <1% | 543 | $510.00 | |
| 90716 | <1% | 161 | $508.20 | |
| 90707 | <1% | 162 | $496.65 | |
| 90461 | <1% | 16 | $432.14 | |
| 90620 | <1% | 264 | $427.35 | |
| 90697 | <1% | 576 | $300.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 28 | $208.00 |
| 90715 | <1% | 310 | $173.25 | |
| 90619 | 0% | 613 | $0.00 | |
| 85018 | 0% | 162 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,255 | $0.00 |
| 85013 | 0% | 159 | $0.00 | |
| 90656 | 0% | 74 | $0.00 | |
| 83655 | 0% | 862 | $0.00 | |
| 80061 | Lipid panel | 0% | 618 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 12 | $0.00 |
| G9920 | Screening performed and negative | 0% | 1,657 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 102 | $0.00 |
| 90661 | 0% | 225 | $0.00 | |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 246 | $0.00 |
| 90700 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.